Select Page

Infinium Global Research has added a new report on Viral Vector and Plasmid DNA Manufacturing Market. The report covers the analysis of global as well as regional markets of viral vector and plasmid DNA manufacturing. Moreover, the report gives insights into the factors that affect the global as well as the regional performance of the market in the short run and in the long run. According to the report, the global viral vector and plasmid DNA manufacturing market is projected to grow at a CAGR of 16.2% over the forecast period of 2019-2025.

Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/13151

Rise in Incidence Rates of Cancer is One of the Major Drivers That Drives the Growth of the Viral Vector and Plasmid DNA Manufacturing Market

The rise in incidence rates of cancer is one of the major drivers that drives the growth of the viral vector and plasmid DNA manufacturing market across the globe. According to Cancer Research UK, nearly 17 million new cases of cancer were there in 2018. The four most common types of cancer worldwide are lung, breast, bowel, and prostate cancers, which account for about 43% of all new cases. Furthermore, genetic disorders and infectious diseases also fuel the growth of the market globally. High unmet needs in patients with rare disorders and raised acceptance for comparatively newer treatment options in developing countries are expected to boost the viral vector & plasmid DNA manufacturing market during the forecast period. However, the high cost of gene therapies may restrain the growth of the market of viral vector & plasmid DNA manufacturing. Moreover, the untapped potential of emerging countries creates an opportunity for the growth of the market in the next few years.

North America is Leading the Global Viral Vector and Plasmid DNA Manufacturing Market

In terms of region, the viral vector & plasmid DNA manufacturing market has been categorized into North America, Europe, Asia-Pacific, and the Rest of the World. North America is leading the global viral vector and plasmid DNA manufacturing market and is estimated to dominate the market growth over the forecast period. This is attributed to the high adoption of viral vector-based products in the United States. The growing rate of cancer and monogenic disorders, rich product pipeline, and technological advancements in the region drives the growth of the viral vector and plasmid DNA manufacturing market in the North American region. The market in the Asia Pacific is expected to grow at a rapid speed over the forecast period. This is attributed to the increased research initiatives in countries like India and the availability of approved gene therapies based on viral vectors in countries such as China and Japan.

Viral Vector and Plasmid DNA Manufacturing Market: Segmentation

The report on the global viral vector and plasmid DNA manufacturing market covers segments such as type, application, disease, and end-user. On the basis of type, the sub-markets include adenovirus, lentivirus, adeno-associated virus, plasmid DNA, and other types. On the basis of application, the sub-markets include gene therapy, vaccinology, and other applications. On the basis of disease, the sub-markets include cancer, genetic disorders, infectious disease, and other disease. On the basis of end-user, the sub-markets include biotech companies, and research institutes.

Browse Detailed TOC and Description of this Exclusive Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-viral-vector-and-plasmid-dna-manufacturing-market

Viral Vector and Plasmid DNA Manufacturing Market: Competitive Landscape

The report provides profiles of the companies in the market such as CobraBiologics, Novasep Inc., Cell and Gene Therapy Catapult, Kaneka Eurogentec S.A., FUJIFILM Diosynth Biotechnologies Inc., Spark Therapeutics, Inc., Merck KGaA, uniQure N.V., and Lonza.

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the Viral Vector and Plasmid DNA Manufacturing.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.